DUK
62
-2
STX
57
-3
CTAS
59
-5
IBM
78
4
CME
37
3
TRV
50
-2
PSX
49
2
FSLR
47
-11
MCD
54
-5
JNPR
63
4
JBHT
49
6
AEE
38
-12
SBUX
35
2
CVX
28
3
NEE
44
-5
BRK.B
34
-2
VIX
25
4
DAL
53
-2
TAP
43
2
STI
17
14
DUK
62
-2
STX
57
-3
CTAS
59
-5
IBM
78
4
CME
37
3
TRV
50
-2
PSX
49
2
FSLR
47
-11
MCD
54
-5
JNPR
63
4
JBHT
49
6
AEE
38
-12
SBUX
35
2
CVX
28
3
NEE
44
-5
BRK.B
34
-2
VIX
25
4
DAL
53
-2
TAP
43
2
STI
17
14
Financhill
Back

First Trust NASDAQ® ABA Community Bk ETF Vs. Keros Therapeutics Industry Stock Comparison

Sell
47

QABA
First Trust NASDAQ® ABA Community Bk ETF

Last Price:
45.65
Seasonality Move:
-0.61%
Sell
27

KROS
Keros Therapeutics

Last Price:
45.71
Seasonality Move:
4.22%
Sell
47
First Trust NASDAQ® ABA Community Bk ETF (QABA) is a Sell

Is First Trust NASDAQ® ABA Community Bk ETF a Buy, Sell or Hold?

  • The current First Trust NASDAQ® ABA Community Bk ETF [QABA] share price is $45.99. The Score for QABA is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • QABA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $45.70. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

QABA Stock Price Chart

What is First Trust NASDAQ® ABA Community Bk ETF's stock price today?

  • The First Trust NASDAQ® ABA Community Bk ETF share price today is $45.99
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QABA is experiencing buying pressure, which is a positive indicator for future bullish movement.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $45.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.

QABA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 60.83 Buy
Chaikin Money Flow: 22378 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.76 - 45.06) Buy
Bollinger Bands (100): (43.93 - 46.09) Buy

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.79 Sell
Relative Strength Index (14 RSI): 38.41 Sell
Chaikin Money Flow: 239305 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.72 - 49.1) Sell
Bollinger Bands (100): (49.87 - 64.91) Sell

QABA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.57 Buy
20-day SMA: 44.28 Buy
50-day SMA: 45.11 Buy
200-day SMA: 44.37 Buy
8-day EMA: 44.74 Buy
20-day EMA: 44.6 Buy
50-day EMA: 44.86 Buy
200-day EMA: 44.95 Buy

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.61 Buy
20-day SMA: 47.29 Sell
50-day SMA: 51.65 Sell
200-day SMA: 47.07 Sell
8-day EMA: 45.93 Sell
20-day EMA: 47.34 Sell
50-day EMA: 50.89 Sell
200-day EMA: 50 Sell

First Trust NASDAQ® ABA Community Bk ETF Earnings Growth & QABA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

First Trust NASDAQ® ABA Community Bk ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):